Stock data
Atara Biotherapeutics, Inc. (ATRA)
Atara Biotherapeutics, Inc. (ATRA) reported revenue of US$120.77M and net income of US$32.69M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$120.77M | — | US$35.86M | US$32.69M | — |
| 2024 | US$128.94M | — | -US$83.44M | -US$85.40M | — |
| 2023 | US$8.57M | — | -US$276.01M | -US$276.13M | — |
| 2022 | — | — | -US$280.51M | -US$228.30M | — |
| 2021 | — | — | -US$340.46M | -US$340.14M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | US$0.63M | -US$4.83M | — |
| 2026-03-31 | US$0.52M | -US$4.14M | — |
| 2025-12-31 | US$1.59M | -US$3.41M | — |
| 2025-09-30 | US$3.45M | -US$4.30M | — |
| 2025-06-30 | US$17.57M | US$2.39M | — |
| 2025-03-31 | US$98.15M | US$38.01M | — |
| 2024-12-31 | US$32.75M | -US$12.69M | — |
| 2024-09-30 | US$40.19M | -US$21.91M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.